Pharma Reaserch Prod Co Ltd Tangible Net Worth Ratio
Pharma Reaserch Prod Co Ltd tangible net worth ratio. Pharma Reaserch Prod Co Ltd (214450) has a Tangible Net Worth Ratio of 97.4% as of December 2025. This metric is calculated by deducting intangible assets (₩18.99 Billion) from net assets (₩723.88 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check strategic asset allocation of Pharma Reaserch Prod Co Ltd to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Pharma Reaserch Prod Co Ltd (2015–2025)
Tangible net worth ratio of Pharma Reaserch Prod Co Ltd from 2015 to 2025. This chart shows how Pharma Reaserch Prod Co Ltd's Tangible Net Worth Ratio has changed across 11 annual periods from 2015 to 2025. As of December 2025, the ratio stands at 97.4%, reflecting net assets of ₩723.88 Billion with intangible assets of ₩18.99 Billion KRW. See Pharma Reaserch Prod Co Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Pharma Reaserch Prod Co Ltd Tangible Net Worth Ratio by Year (2015–2025)
Pharma Reaserch Prod Co Ltd tangible net worth ratio by year from 2015 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Pharma Reaserch Prod Co Ltd from 2015 to 2025, covering 11 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Pharma Reaserch Prod Co Ltd (214450) total market value.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.4% | ₩723.88 Billion | ₩18.99 Billion | ₩1.04 Trillion | ▲ +0.8 pp |
| 2024 | 96.6% | ₩569.44 Billion | ₩19.54 Billion | ₩855.70 Billion | ▲ +1.0 pp |
| 2023 | 95.6% | ₩462.19 Billion | ₩20.32 Billion | ₩535.28 Billion | ▲ +2.6 pp |
| 2022 | 93.0% | ₩343.50 Billion | ₩24.02 Billion | ₩478.06 Billion | ▲ +1.5 pp |
| 2021 | 91.5% | ₩305.44 Billion | ₩26.02 Billion | ₩427.65 Billion | ▲ +2.4 pp |
| 2020 | 89.1% | ₩245.42 Billion | ₩26.81 Billion | ₩319.83 Billion | ▲ +3.3 pp |
| 2019 | 85.7% | ₩209.07 Billion | ₩29.81 Billion | ₩269.93 Billion | ▲ +1.9 pp |
| 2018 | 83.8% | ₩197.62 Billion | ₩31.98 Billion | ₩258.19 Billion | ▼ -14.9 pp |
| 2017 | 98.7% | ₩178.85 Billion | ₩2.28 Billion | ₩189.03 Billion | ▲ +0.1 pp |
| 2016 | 98.7% | ₩171.64 Billion | ₩2.29 Billion | ₩179.33 Billion | ▼ -0.3 pp |
| 2015 | 98.9% | ₩156.75 Billion | ₩1.65 Billion | ₩169.31 Billion | — |